NIENTE DA FARE: IL TRAPIANTO FECALE NON SERVE PER INDURRE REMISSIONE NEL CROHN. UN TRIAL CANADESE IN DOPPIO CIECO SU 3 CENTRI TERMINATO PER FUTILITA’. DA “AJG” (FREE!)

GASTROENTEROLOGIA, IBD, MEDICINA DEI PROBIOTICI, NEWSLETTER

Preliminary Results From a Multicenter, Randomized Trial Using Fecal Microbiota Transplantation to Induce Remission in Patients With Mild-to-Moderate Crohn’s Disease Kao, Dina et al. Abstract INTRODUCTION: Fecal microbiota transplantation (FMT) has shown promise at inducing remission in ulcerative colitis. This study is the first of its kind to evaluate the efficacy and safety of FMT…

RIFAXIMINA: UNA NARRATIVE REVIEW SUL SUO RUOLO IN GASTROENTEROLOGIA. DA “GE – Portuguese Journal of Gastroenterology” (FREE!)

DISPEPSIA, GASTROENTEROLOGIA, IBS, NEWSLETTER

Rifaximin as a Therapeutic Ally in the Modulation of Dysbiosis: A Narrative Review of Its Applicability in Gastrointestinal Disorders Joana Friasa et al. Abstract Background: The gastrointestinal microbiota is vital for a well-functioning digestive tract, nutrient metabolism, immune support, and protection against pathogenic microorganisms. Disruption of this balance is known as dysbiosis. Rifaximin, an oral antibiotic…